Storia in 6 fonti

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Indian pharma stocks are likely to remain in focus after US President Donald Trump announced a phased tariff plan for generic medicines, offering a two-year tariff exemption before imposing steep duties from 2028.

Raccontata da

timesofindia.indiatimes.com

economictimes.indiatimes.com

hindustantimes.com

thehindubusinessline.com

newsbytesapp.com

theprint.in

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo1 mese fa

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

originale

Timeline cronologica

mercoledì 22 luglio 2026·timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
mercoledì 22 luglio 2026·economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Trump ⁠has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Confronto fonti

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla…

Stocks fall, pharma firms fret. Indian drug manufacturers sweat over Trump's 100% levy on generics

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Trump's generic drugs tariff threatens Indian pharma's top market

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

US to impose steep tariffs on generic medicine imports from Aug 2028

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Trump threatens tariff on generic medicines: Should India be worried?

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Pharma stocks decline; Aurobindo Pharma down over 4%

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive